Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
11.24
-0.02 (-0.18%)
Apr 29, 2026, 3:04 PM CST
-0.27%
Market Cap 11.67B
Revenue (ttm) 5.06B
Net Income (ttm) 355.69M
Shares Out 1.04B
EPS (ttm) 0.29
PE Ratio 38.57
Forward PE n/a
Dividend 0.10 (0.89%)
Ex-Dividend Date n/a
Volume 9,168,711
Average Volume 20,643,017
Open 11.65
Previous Close 11.26
Day's Range 11.20 - 11.65
52-Week Range 11.07 - 16.66
Beta 0.83
RSI 33.16
Earnings Date Apr 24, 2026

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

In 2025, Yifan Pharmaceutical's revenue was 5.13 billion, a decrease of -0.52% compared to the previous year's 5.16 billion. Earnings were 402.02 million, an increase of 4.16%.

Financial Statements

News

There is no news available yet.